share_log

BRIEF-Medigus Polyrizon To Initiate Processes Towards FDA Submission

BRIEF-Medigus Polyrizon To Initiate Processes Towards FDA Submission

简报-Medigus Polyrizon将启动向FDA提交的程序
reuters ·  2021/10/22 07:40

Oct 22 (Reuters) - Medigus Ltd 2QMy.F :

路透10月22日电-Medigus Ltd 2QMy.F:

* MEDIGUS: POLYRIZON TO INITIATE PROCESSES TOWARDS FDA SUBMISSION

*Medigus:POLYRIZON将启动向FDA提交的程序

* MEDIGUS LTD - POLYRIZON ENGAGED WITH A CRO TO OVERSEE POLYRIZON'S EFFORTS FOR FDA SUBMISSION OF ITS CORONAVIRUS AND ALLERGEN PREVENTATIVE PRODUCTS

*Medigus Ltd-POLYRIZON与CRO合作,监督POLYRIZON为FDA提交其冠状病毒和过敏原预防产品所做的努力

Source text for Eikon: ID:nGNXN311H Further company coverage: 2QMy.F

Eikon的源文本:ID:nGNXN311H进一步的公司报道:2QMy.F

((Reuters.Briefs@thomsonreuters.com;))

(Reurs.Briefs@thomsonreurs.com;)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发